Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
36.94
-0.11 (-0.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.14 billion as of April 25, 2025. Its market cap has decreased by -27.96% in one year.
Market Cap
2.14B
Enterprise Value
1.42B
1-Year Change
-27.96%
Ranking
Category
Stock Price
$36.94
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.14B, an increase of 164.63%. That is a compound annual growth rate of 72.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 2.14B | -16.96% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |